Internet Brands’ WebMD Acquires QxMD

The acquisition, announced today, combines QxMD’s unrivaled online clinical calculators and other digital learning tools for HCPs with the content, reference, point-of-care and crowdsourcing solutions of Medscape, the leading digital news, information and continuing medical education platform for physicians and HCPs worldwide. Medscape is a division of WebMD Health Corp.

“QxMD is an important addition to the Medscape brand and strengthens our commitment to deliver best-in-class solutions to support patient care,” said Jeremy Schneider, Senior Vice President and Group General Manager, WebMD Global. “Their robust medical calculators are used by physicians in over 150 countries and further expand Medscape’s global footprint to now reach over 4 million physicians worldwide.”   

“Medscape is a terrific fit for QxMD,” said Daniel Schwartz, M.D., QxMD CEO & Medical Director.  “The company shares our commitment to digital innovation that streamlines and enhances clinical practice and improves patient care.  Through Medscape’s unparalleled reach and engagement, we will be able to have an even greater impact on physicians, health care professionals, and their patients.”      

QxMD will continue to operate as an independent subsidiary of WebMD Health Corp.  Terms of the transaction were not made public. 

About QxMD
QxMD™ is a digital learning technology company that makes it easier for healthcare professionals (HCPs) to discover the latest evidence and decision support tools for use in clinical practice. The company’s HCP engagement platform comprises a library of trusted apps that provide millions of members with fast access to full-text research, continuing medical education (CME), and up-to-date tools that drive disease recognition and therapy optimization. Powered by a sophisticated personalization engine, the platform aggregates PubMed feeds, journal table of contents (TOCs), 450+ diagnostic tools, micro-CME courses and more. QxMD also serves other healthcare constituents such as hospitals, libraries, scholarly publishers, and nearly 50% of the world’s top-25 pharmaceutical companies.

1 2 3 4